Get started
Author

Sabina A. Guler

Observed names: Guler S, Guler Sabina, Guler, Sabina, Guler, Sabina A, Guler, Sabina A., S A Guler, S Guler, S. Guler, S.A. Guler, Sabina A. Guler, Sabina Anna Guler, Sabina A Guler, Sabina Anna Guler, Sabina Guler, Sabina A. Guler
ORCID: 0000-0002-9833-5911
Observed ORCID: 0000-0002-9833-5911
OpenAlex ID: A5025858579
Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study
2021 · Sabina A. Guler, Lukas Ebner, et al. · European Respiratory Journal · 407
PDF
Progression of fibrosing interstitial lung disease
2020 · Alyson W. Wong, Christopher J. Ryerson, et al. · Respiratory Research · 185
PDF
YouTube Videos as a Source of Misinformation on Idiopathic Pulmonary Fibrosis
2019 · Gillian C. Goobie, Sabina A. Guler, et al. · Annals of the American Thoracic Society · 158
Early diagnosis of fibrotic interstitial lung disease: challenges and opportunities
2021 · Paolo Spagnolo, Christopher J Ryerson, et al. · The Lancet Respiratory Medicine · 144
Heterogeneity in Unclassifiable Interstitial Lung Disease. A Systematic Review and Meta-Analysis
2018 · Sabina A. Guler, Kina Ellison, et al. · Annals of the American Thoracic Society · 109
Does Systemic Sclerosis–Associated Interstitial Lung Disease Burn Out? Specific Phenotypes of Disease Progression
2018 · Sabina A. Guler, Tiffany A. Winstone, et al. · Annals of the American Thoracic Society · 108
Effects of zoledronate versus placebo on spine bone mineral density and microarchitecture assessed by the trabecular bone score in postmenopausal women with osteoporosis: A three-year study
2012 · Albrecht W Popp, Sabina Guler, et al. · Journal of Bone and Mineral Research · 97
PDF
Body composition, muscle function, and physical performance in fibrotic interstitial lung disease: a prospective cohort study
2019 · Sabina A. Guler, Seo Am Hur, et al. · Respiratory Research · 67
PDF
Functional ageing in fibrotic interstitial lung disease: the impact of frailty on adverse health outcomes
2019 · Sabina A. Guler, Joanne M. Kwan, et al. · European Respiratory Journal · 59
PDF
Frailty is common and strongly associated with dyspnoea severity in fibrotic interstitial lung disease
2016 · Kathryn M. Milne, Joanne M. Kwan, et al. · Respirology · 57
Global epidemiology and burden of interstitial lung disease
2025 · Paolo Spagnolo, Sabina A Guler, et al. · The Lancet Respiratory Medicine · 54
Occupational interstitial lung diseases
2023 · Paolo Spagnolo, Christopher J. Ryerson, et al. · Journal of Internal Medicine · 50
Incidence and Prognostic Significance of Hypoxemia in Fibrotic Interstitial Lung Disease
2021 · Yet H. Khor, Lawrence Gutman, et al. · CHEST Journal · 48
PDF
Survival after inpatient or outpatient pulmonary rehabilitation in patients with fibrotic interstitial lung disease: a multicentre retrospective cohort study
2021 · Sabina Anna Guler, Seo Am Hur, et al. · Thorax · 46
A contemporary practical approach to the multidisciplinary management of unclassifiable interstitial lung disease
2021 · Christopher J. Ryerson, Tamera J. Corte, et al. · European Respiratory Journal · 44
PDF
Minimal Important Difference for Physical Activity and Validity of the International Physical Activity Questionnaire in Interstitial Lung Disease
2018 · Seo Am Hur, Sabina A. Guler, et al. · Annals of the American Thoracic Society · 42
Severity and features of frailty in systemic sclerosis-associated interstitial lung disease
2017 · Sabina A. Guler, Joanne M. Kwan, et al. · Respiratory Medicine · 40
Interstitial Lung Disease in 2020
2021 · Sabina A. Guler, Tamera J. Corte · Clinics in Chest Medicine · 34
PDF
Phenotyping by persistent inflammation in systemic sclerosis associated interstitial lung disease: a EUSTAR database analysis
2023 · Sabina Guler, Adela-Cristina Sarbu, et al. · Thorax · 33
PDF
Frailty in patients with interstitial lung disease
2020 · Sabina A. Guler, Christopher J. Ryerson · Current Opinion in Pulmonary Medicine · 32
Pectoralis muscle area and its association with indices of disease severity in interstitial lung disease
2021 · Yannick Molgat-Seon, Sabina A. Guler, et al. · Respiratory Medicine · 29
Costs of Workplace Productivity Loss in Patients With Fibrotic Interstitial Lung Disease
2019 · Mohmmed Algamdi, Mohsen Sadatsafavi, et al. · CHEST Journal · 29
Frailty assessment for COVID-19 follow-up: a prospective cohort study
2022 · Ilena Müller, Marco Mancinetti, et al. · BMJ Open Respiratory Research · 27
PDF
Serum calprotectin as new biomarker for disease severity in idiopathic pulmonary fibrosis: a cross-sectional study in two independent cohorts
2021 · Carlos Machahua, Sabina A. Guler, et al. · BMJ Open Respiratory Research · 27
PDF
Pulmonary Recovery 12 Months after Non-Severe and Severe COVID-19: The Prospective Swiss COVID-19 Lung Study
2022 · Alexandra Lenoir, Andreas Christe, et al. · Respiration · 25
PDF
Works count: 139
Citation count: 2,329
H-index: 25
I10-index: 39
Year
Topic
Type